Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

The American Society of Pediatric Hematology Oncology workforce, productivity, and fellowship assessment: Current state of the workforce.

  • Read more about The American Society of Pediatric Hematology Oncology workforce, productivity, and fellowship assessment: Current state of the workforce.

Data standards in pediatric oncology: Past, present, and future.

  • Read more about Data standards in pediatric oncology: Past, present, and future.

Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions.

  • Read more about Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions.

Subcutaneous panniculitis-like T-cell lymphomas with homozygous inheritance of HAVCR2 mutations in Vietnamese pedigrees.

  • Read more about Subcutaneous panniculitis-like T-cell lymphomas with homozygous inheritance of HAVCR2 mutations in Vietnamese pedigrees.

Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.

  • Read more about Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.

Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience.

  • Read more about Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience.

Zinc deficiency and its association with treatment-related toxicity in children with cancer.

  • Read more about Zinc deficiency and its association with treatment-related toxicity in children with cancer.

A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

  • Read more about A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

Musculoskeletal impairments in children receiving intensive therapy for acute leukemia or undergoing hematopoietic stem cell transplant: A report from the Children's Oncology Group.

  • Read more about Musculoskeletal impairments in children receiving intensive therapy for acute leukemia or undergoing hematopoietic stem cell transplant: A report from the Children's Oncology Group.

Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia.

  • Read more about Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia.

Pagination

  • Previous page ‹‹
  • Page 5
  • Next page ››
Subscribe to Pediatric blood & cancer

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List